Biotechnology Stocks I Performance Guide: Rocket Pharmaceuticals, Inc. (RCKT)
RCKT has no dividends
Table and Chart of RCKT Performance
See what a $1,000 investment in RCKT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RCKT Returns | |
|---|---|
| Start Date | Mar-31-2015 |
| Start Price | $21.68 |
| End Date | Dec-01-2023 |
| End Price | $23.42 |
| # Prices | 106 |
| Min Date | Jul-31-2017 |
| Min Price | $3.65 |
| Max Date | Feb-26-2021 |
| Max Price | $55.58 |
| Total Return | 8.03% |
| Annualized Return | 0.88% |
| Current Value of $1,000 Purchase | $1,080 |
| Number Returns | 5,565 |
| Average Return | 34.49% |
| Number Profitable Returns | 2,641 |
| Percent Profitable Returns | 47.46% |
| Number Unprofitable Returns | 2,924 |
| Percent Unprofitable Returns | 52.54% |
| Profitable to Unprofitable Returns Ratio | 0.90 |
| RCKT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,114,229,000 | Price to Sales |
| Earnings per Share | $-3.1900 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 3.897 |
| PRICE DATA | |
| 52 Week High | $24.74 |
| 52 Week Low | $14.89 |
| Analyst Target Price | $51.75 |
| 50-Day Moving Average | $19.72 |
| 200-Day Moving Average | $19.17 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -0.556% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RCKT Compare Returns with S&P 500
RCKT Trendline Chart